News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,529 Results
Type
Article (15047)
Company Profile (297)
Press Release (269177)
Multimedia
Podcasts (86)
Webinars (12)
Section
Business (79933)
Career Advice (164)
Deals (13372)
Drug Delivery (40)
Drug Development (50763)
Employer Resources (31)
FDA (5878)
Job Trends (5180)
News (145303)
Policy (10092)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (930)
Accelerated approval (23)
Adcomms (14)
Allergies (94)
Alliances (21765)
ALS (147)
Alzheimer's disease (1087)
Antibody-drug conjugate (ADC) (292)
Approvals (6102)
Artificial intelligence (310)
Autoimmune disease (175)
Automation (9)
Bankruptcy (105)
Best Places to Work (4562)
BIOSECURE Act (6)
Biosimilars (112)
Biotechnology (230)
Bladder cancer (114)
Brain cancer (52)
Breast cancer (369)
Cancer (3474)
Cardiovascular disease (268)
Career advice (149)
Career pathing (8)
CAR-T (235)
CDC (6)
Cell therapy (614)
Cervical cancer (19)
Clinical research (44198)
Collaboration (1294)
Company closure (2)
Compensation (656)
Complete response letters (50)
COVID-19 (1112)
CRISPR (95)
C-suite (637)
Cystic fibrosis (115)
Data (4866)
Denatured (17)
Depression (105)
Dermatology (35)
Diabetes (275)
Diagnostics (1406)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (227)
Drug pricing (51)
Drug shortages (3)
Duchenne muscular dystrophy (254)
Earnings (32209)
Editorial (28)
Employer branding (4)
Employer resources (29)
Events (52335)
Executive appointments (652)
FDA (7818)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1085)
Gene editing (199)
Generative AI (27)
Gene therapy (540)
GLP-1 (534)
Government (1165)
Grass and pollen (3)
Guidances (171)
Healthcare (6639)
HIV (23)
Huntington's disease (47)
IgA nephropathy (78)
Immunology and inflammation (212)
Immuno-oncology (60)
Indications (103)
Infectious disease (1242)
Inflammatory bowel disease (165)
Inflation Reduction Act (10)
Influenza (48)
Intellectual property (183)
Interviews (18)
IPO (7360)
IRA (13)
Job creations (868)
Job search strategy (130)
JPM (41)
Kidney cancer (9)
Labor market (25)
Layoffs (247)
Leadership (10)
Legal (1405)
Liver cancer (42)
Longevity (19)
Lung cancer (465)
Lymphoma (271)
Machine learning (28)
Management (7)
Manufacturing (428)
MASH (142)
Medical device (2681)
Medtech (2691)
Mergers & acquisitions (6680)
Metabolic disorders (807)
mRNA (126)
Multiple sclerosis (112)
NASH (14)
Neurodegenerative disease (283)
Neuropsychiatric disorders (74)
Neuroscience (2122)
Neurotech (1)
NextGen: Class of 2026 (2036)
Non-profit (872)
Now hiring (36)
Obesity (370)
Opinion (132)
Ovarian cancer (142)
Pain (116)
Pancreatic cancer (178)
Parkinson's disease (272)
Partnered (12)
Patents (342)
Patient recruitment (414)
Peanut (46)
People (26883)
Pharmaceutical (42)
Pharmacy benefit managers (6)
Phase 1 (15655)
Phase 2 (20556)
Phase 3 (12963)
Pipeline (4456)
Policy (98)
Postmarket research (853)
Preclinical (6605)
Press Release (30)
Prostate cancer (168)
Psychedelics (51)
Radiopharmaceuticals (253)
Rare diseases (776)
Real estate (1449)
Recruiting (12)
Regulatory (10197)
Reports (20)
Research institute (977)
Resumes & cover letters (20)
Rett syndrome (29)
RNA editing (22)
RSV (21)
Schizophrenia (132)
Series A (209)
Series B (147)
Service/supplier (1)
Sickle cell disease (85)
Special edition (19)
Spinal muscular atrophy (124)
Sponsored (16)
Startups (2016)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (18)
The Weekly (67)
Vaccines (366)
Venture capital (77)
Weight loss (195)
Women's health (34)
Worklife (2)
Date
Today (81)
Last 7 days (410)
Last 30 days (1699)
Last 365 days (17920)
2026 (4440)
2025 (18115)
2024 (20560)
2023 (22425)
2022 (26834)
2021 (27827)
2020 (23373)
2019 (16231)
2018 (11741)
2017 (13747)
2016 (11841)
2015 (14352)
2014 (10395)
2013 (7487)
2012 (7533)
2011 (7617)
2010 (7429)
Location
Africa (154)
Alabama (69)
Alaska (2)
Arizona (76)
Arkansas (6)
Asia (18426)
Australia (3155)
California (7714)
Canada (1988)
China (866)
Colorado (274)
Connecticut (278)
Delaware (256)
Europe (39590)
Florida (984)
Georgia (225)
Hawaii (2)
Idaho (17)
Illinois (442)
India (39)
Indiana (177)
Iowa (8)
Japan (259)
Kansas (82)
Kentucky (10)
Louisiana (12)
Maine (11)
Maryland (797)
Massachusetts (6062)
Michigan (119)
Minnesota (273)
Mississippi (3)
Missouri (34)
Montana (17)
Nebraska (6)
Nevada (40)
New Hampshire (21)
New Jersey (1788)
New Mexico (13)
New York (1910)
North Carolina (886)
North Dakota (6)
Northern California (3859)
Ohio (188)
Oklahoma (11)
Oregon (24)
Pennsylvania (1411)
Puerto Rico (9)
Rhode Island (27)
South America (216)
South Carolina (10)
Southern California (3060)
Tennessee (46)
Texas (1010)
United States (25392)
Utah (105)
Virginia (156)
Washington D.C. (37)
Washington State (632)
West Virginia (1)
Wisconsin (49)
284,529 Results for "rezo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Rezo Therapeutics Appoints Nadir Mahmood, Ph.D., as Chief Executive Officer
Rezo Therapeutics today announced the appointment of Nadir Mahmood, Ph.D., as chief executive officer and board member.
September 20, 2023
·
2 min read
Biotech Bay
Rezo Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Rezo Therapeutics announced today that Nevan Krogan, Ph.D., co-founder and chief executive officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
January 9, 2023
·
1 min read
Biotech Bay
Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million Series A to Advance Pipeline of Precision Therapeutics Based on Groundbreaking Integrated Disease Network Mapping Platform
Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, launched with $78 million from a Series A financing.
November 17, 2022
·
4 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Defence Therapeutics Announces Warrant Terms Amendment
March 20, 2026
·
3 min read
FDA
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
While ersodetug missed the Phase 3 primary endpoint of a reduction in hypoglycemia events, Rezolute argued that this goal was confounded in part by behavioral factors. The FDA acknowledged the validity of this argument.
March 24, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 13, 2026
·
14 min read
Press Releases
Asha Therapeutics Launches as First Atom Therapeutics, a Zero-Shot De Novo Drug Design Company
March 30, 2026
·
2 min read
Press Releases
Kenai Therapeutics Appoints Allen Waldrop to Board of Directors
March 13, 2026
·
3 min read
Press Releases
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
March 31, 2026
·
10 min read
1 of 28,453
Next
